COVID-19
It will take months or possibly years to definitively appreciate how the COVID-19 pandemic will affect people with
Isradipine Results
The results of the STEADY-PD III trial have now been published. There was no evidence that
Exosomes 2
Alpha synuclein found in exosomes has been shown to differentiate Parkinson’s from other related conditions, outperforming previous ways of
Another angle on the possible neuroprotective effects of statins
A study investigating the potential neuroprotective effects of statins in Progressive Supranuclear Palsy (PSP) has found they may be associated with less severe movement problems and a delay in disease onset.
Living with Parkinson’s during the COVID-19 outbreak
Information and advice on how to take care of yourself and your Parkinson’s during the COVID-19 outbreak
Powered by
Science with
